Skip to content

Clinical trials

Phase 2 Gliosarcoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gliosarcoma Phase: Phase 2 Clear all

178 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
200111
20028
20036
20048
200512
200613
200716
200815
200912
201010
20116
20125
20136
20141
20154
20161
20172
20182
20193
20211
20231
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed129
Terminated27
Unknown status9
Withdrawn6
Active, not recruiting5
Suspended1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)30
Duke University22
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins11
European Organisation for Research and Treatment of Cancer - EORTC7
Jonsson Comprehensive Cancer Center5
Radiation Therapy Oncology Group5
University of California, San Francisco5
Alliance for Clinical Trials in Oncology4
Memorial Sloan Kettering Cancer Center4
Northwestern University4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gliosarcoma178
Glioblastoma176
Brain Neoplasms99
Central Nervous System Neoplasms81
Astrocytoma61
Glioma60
Oligodendroglioma44
Ependymoma15
Glioma, Subependymal11
Medulloblastoma7

Trials

Showing 76 to 100 of 178. Each trial links to its page on Pharma Observatory.

78 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.